Physician profile
Omar Viswanath
NPI 1669813994
$41,529.44
in general payments reported to CMS, 2019-2025
32 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,800 · 2020: $2,267 · 2021: $1,763 · 2022: $7,572 · 2023: $2,474 · 2024: $2,927 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $7,126 · Travel and Lodging: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,365.00 |
| Food and Beverage | $7,125.62 |
| Travel and Lodging | $637.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $18,559.53 | 2024-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $16,356.82 | 2019-2025 | Proclaim, Octrode, Eterna |
| Grt US Holding, INC. | $2,125.08 | 2019 | |
| Medtronic USA, INC. | $1,652.61 | 2019-2020 | |
| Nevro Corp. | $959.49 | 2019-2023 | Senza |
| Si-Bone, INC. | $540.28 | 2023-2025 | |
| Medtronic, INC. | $284.39 | 2023-2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Relievant Medsystems, INC. | $180.89 | 2023 | Intracept |
| Boston Scientific Corporation | $170.12 | 2019-2025 | Intracept |
| Vertos Medical, INC. | $138.98 | 2024 | Mild Device Kit |
| Electronic Waveform Lab, INC. | $51.85 | 2025 | |
| Biodelivery Sciences International, INC. | $50.34 | 2020 | |
| Allergan, INC. | $42.56 | 2019 | |
| Saluda Medical Americas, INC. | $40.20 | 2024 | Evoke |
| Ferring Pharmaceuticals INC. | $37.10 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $34.37 | 2024 | Sprint Pns System |
| Abbvie INC. | $34.36 | 2025 | |
| Sanofi-Aventis U.S. LLC | $29.29 | 2019-2020 | |
| Fidia Pharma USA INC. | $24.27 | 2022 | |
| Collegium Pharmaceutical, INC. | $23.78 | 2020 | |
| Amgen INC. | $23.65 | 2019 | |
| Globus Medical, INC. | $21.66 | 2025 | Senza |
| West Therapeutics Development, LLC | $20.21 | 2019 | |
| Pfizer INC. | $17.79 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.38 | 2020 | |
| Pacira Therapeutics, INC. | $16.06 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.61 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $14.60 | 2019 | |
| Mdd US Operations, LLC | $12.60 | 2019 | |
| Team_makena_llc | $12.53 | 2019 | |
| Forte Bio-Pharma LLC | $11.81 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Viswanath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.